Postpartum haemorrhage. haemorrhage after delivery of fetus or infant
Conditions
Interventions
Intervention 1: Control group:20 units of oxytocin in 1000 cc of Ringer's solution and 100 cc of the placebo syrup will be administered to the women in labor in two doses of immediately and 30 minutes
Placebo
Treatment - Drugs
Control group:20 units of oxytocin in 1000 cc of Ringer's solution and 100 cc of the placebo syrup will be administered to the women in labor in two doses of immediately and 30 minutes after the expul
Intervention group:20 units of oxytocin in 1000 cc of Ringer's solution and 100 cc of Plantago major extract 20% will be administered to the women in labor in two doses, one immediately and one 30 min
Sponsors
Vice-Chancellor for Research of Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
Female
Age
20 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Age of 20 to 35 years old, less than 3 pregnancies, gestational age between 37 to 42 weeks, singleton pregnancy with cephalic presentation and a fetal weigh between 2,500 to 4,000 grams, no pregnancy complications, no history of cesarean section or surgery on the uterus or postpartum hemorrhage, no systemic diseases, no magnesium sulfate consumption during pregnancy, clarity of the amniotic fluid during the first stage of labor, lack of wide episiotomy (rupture of grade 3 and 4) during the second stage of labor, normal duration of the first, second and third stages of labor, no severe postpartum hemorrhage, no severe hemorrhage during labor. Exclusion criteria:Hemorrhage during labor, unwillingness to continue to participate in the study, allergy to Plantago major, caesarean section.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount of bleeding after delivery of the placenta and fetus. Timepoint: Every one hour for six hours. Method of measurement: Weighing pads and gowns in the first, second, third and sixth hour. | — |
Secondary
| Measure | Time frame |
|---|---|
| -. Timepoint: -. Method of measurement: -. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahrokh Dolatian
Shahid Beheshti University of Medical Science
Outcome results
None listed